Benefits of Calibration:
Embozene microspheres allow for a strong correlation
between microsphere size and the diameter of vessel occlusion;
Precisely calibrated sizing decreases risk of premature vessel occlusion;
Greater confidence when performing superselective and targeted embolizations.
Benefits of Easy-to-Maintain Suspensions: Easily suspends in contrast media and maintains homogeneous suspensions; Ensures smooth delivery through a Microcatheter; Enables physician to concentrate on the screen; Reduces risk of microcatheter occlusion.
Benefits of Structural Resiliency: Compressible up to 30% for smooth delivery through a catheter; Elasticity allows for the microspheres to rebound to their original shape after compression; Robustness prevents clumping and fragmentation during delivery.
Benefits of Biocompatibility: Preclinical studies show that both the core and shell are biocompatible with low levels of inflammation; Highly Biocompatible hydrogel microspheres coated with Polyzene®-F.
Indications for use of Embozene microspheres:
1. Fibroids of the uterus
2. Swollen head, neck, torso and skeletal system
3. Neurovascular and peripheral arteriovenous malformations
4. Hepatocellular carcinomas
5. Bleeding and trauma
6. Preoperative preparation to reduce the risk of bleeding (except for operations on the central nervous system)
Wide range of sizes offered in 1 and 2 mL syringes From 40 μm to 1300 μm Sold in single syringe units Color-coded to enhance visualization and aid in size recognition Three-year shelf life from the date of manufacture
Emozene TANDEM drug-eluting microspheres are finely calibrated small microspheres for controlled embolization. The product has unique dimensions specially designed for deep penetration into the tumor, in particular 40, 75 and 100 microns. The use of the product reduces the risk of premature vascular occlusion for deep-targeted embolization.
Indications for use of Embozene TANDEM drug-coated microspheres:
1. Microspheres intended for use in embolization of blood vessels supplying primary hypervascular tumors or liver metastases.
Precisely calibrated to give more opportunities for embolization.
The size of the microspheres remains stable during loading and storage of drugs; the typical size change is less than 5%.
Fast loading times for drugs (30-120 minutes depending on prescription). Possibility of loading up to 50 mg drug / ml microspheres: - doxorubicin-HCl powder or solution - irinotecan-HCl Three sizes offered in 2 and 3 ml product per syringe from 40 to 100 microns. Three-year shelf life from the date of manufacture
Cryo Care Touch is a fully integrated, highly precise ablation treatment system featuring a new intuitive touch screen interface, improved compact design, and software upgrades that offer a predictable therapy delivery with exceptional case of technical operation.
Touch screen monitor:
• Includes an integrated touch screen user interface to control and monitor the procedure
• May be titled and rotated up to 190 degrees for optimal viewing
• Handles can be locked in the up position for easy transport
• 2 lockable swiveling casters and 2 directional wheels
• Displays a real-time readout of the argon and helium system pressures during the procedure
Remote Control Keypad:
• Alternative control for operating the Cryo Care Touch System
Temp Probe Connections:
Connect up to eight (A-H), independent Temp Probes
Cryo probe Connections:
Connect up to eight (1-8), single –use, disposable cryo probes
Compact, easy-to-operate console
Interventional Radiologists can treat almost any cancer.
Indications For Use
The Cryocare Touch System intended for use in open, minimally invasive or endoscopic procedures in the areas of general surgery, urology, gynecology, oncology, dermatology, ENT, proctology, pulmonary surgery and thoracic surgery. The system designed to freeze/ablate tissue by the application of extreme cold temperatures including prostate and kidney tissues, liver metastases, tumors, skin lesions, and warts.
In addition the Cryocare Touch System is intended for use in the following indications:
Destruction of warts or lesions; Palliation of tumors of the oral cavity, rectum and skin; Ablation of breast fibro adenomas; Ablation of leukoplakia of the mouth, angiomas sebaceous hyperplasia, basal cell tumors of the eyelid or canthus area, ulcerated basal cell tumors, dermatofibromas, small hemangiomas, mucocele cysts, multiple warts, plantar warts, hemorrhoids, anal fissures, perianal condylomata, pilonidal cysts, actinic and seborrheic keratosis, cavernous hemangiomas, recurrent cancerous lesions.
Ablation of prostate tissue in cases of prostate cancer and benign prostatic hyperplasia.
Ablation of malignant neoplasia or benign dysplasia of the female genitalia.
Ablation of cancerous or malignant tissue; Ablation of benign tumors; Palliative intervention.
Freezing of nerve tissue in pain management/cryoanalgesia.
Ablation or freezing of skin.
Ablation of benign or malignant growths of the anus or rectum; Ablation of hemorrhoids.
Ablation of cancerous lesions.
Integrated ultrasound imaging (CS v. 4 & 5)
CryoGuide™ planning software
Individual probe control TempProbe™ temperature monitoring system
Closed-loop urethral warming system
For interventional radiology:
Excellent visibility under image guidance Multiple cryoprobes used simultaneously can create a large ablation zone.
Wide selection of cryoprobes
Integrated thermocouple in every cryoprobe Multiple ice ball sizes, probe lengths and diameters Patented design
The Nano Knife 3.0 is the first IRE system, which intended to use in oncology, and is a brand new technology in focal ablation therapy.
Expanding the Boundaries of Ablation
The Nano Knife 3.0 System is expanding the boundaries of modern-day ablation. Its unique Irreversible Electroporation (IRE) technology does not rely on heat to achieve cell death. It uses a more natural method that destroys only targeted tissue, sparing critical structures including vessels, nerves and ducts.1234 With the Nano Knife 3.0 System comes an enhanced user experience– streamlining procedure set up and delivering real-time visual feedback.
About the IRE Technology Behind the Nano Knife System
Irreversible electroporation (IRE) is a technique using a non-thermal energy to create permanent nanopores in the cell membrane to disrupt cellular homeostasis. The disruption of cellular homeostasis initiates an apoptotic-like effect, which leads to permanent cell death. After delivering a sufficient number of high voltage pulses, the cells within the electrical field will be irreversibly damaged.
The uniqueness of the technology:
Nano Knife 3.0 device is intended to use in following deceases treatment:
The Nano Knife system allows you to act on tumors located near vessels, nerve bundles and ducts, expanding the possibilities of treating cancer patients.
In non-resection pancreatic adenocarcinoma, IRE, in combination with chemotherapy and / or radiation therapy, leads to an increase in patient survival, as follows from the graph below. The median survival in this study (Robert CG Martin et al) was 28.3 months (Electroporation + resection, 50 patients) and 23.2 months. (Electroporation only, 150 patients)
When treating adenocarcinoma of the prostate gland, the use of Nano Knife almost never leads to the occurrence of erectile dysfunction. In addition, in the treatment of this disease, there is the possibility of repeated exposure, including after other types of interventions (HIFU, brachytherapy). The IRE method provides a low likelihood of complications and functional impairment.
The DIRECT Study for Stage III Pancreatic Cancer
The DIRECT study, sponsored by Angio Dynamics, Inc., is an FDA-approved clinical study that is evaluating the effectiveness of IRE technology for the treatment of stage III pancreatic cancer.
How Nano Knife 3.0 works:
The Nano Knife System uses electrical pulses of up to 3000 volts, which delivered through multiple needle probes placed in and / or around the ablation zone under ultrasound guidance. Under the influence of high voltage pulses, the membranes of malignant cells irreversibly damaged. Cells die, and waste products removed by the lymphatic system and because of a macrophage reaction. The procedure performing under general anesthesia and requires muscle relaxation. When performing electroporation with the Nano Knife, blood vessels, ducts and stromal structures - both inside and near the ablation zone - not damaged, which confirmed by the conducted studies.
Irreversible electroporation (IRE) differs from other ablation methods that use extreme high or low temperatures. The radical difference when using the Nano Knife IRE system is that there is no heat dissipation problem. Removal of the products of cell destruction occurs because of natural processes for several weeks (imitation of natural cell death).
The Solero* Microwave Tissue Ablation (MTA) System and Accessories are indicated for the ablation of soft tissue during open procedures. The Solero MTA System not intended for cardiac use. The Solero MTA System is unique because is specially designed to complete up to a 5 cm ablation in 6 minutes at max power output using a single applicator. The Solero MTA System is able to accomplish this through the innovative solid-state generator and specially designed applicator.
Solero Microwave Generator
Solero Microwave Applicator
The SKATER drainage catheter designed for draining cavities according to the Seldinger technique.
The catheter is made of soft polyurethane, which prevents twisting and ensures excellent memory of its configuration. Pigtail tip, large oval drainage holes and large lumen provide maximum drainage capacity.
The catheter covered with a layer of HYDROFEEL material for minimal friction during insertion. Supplied with removable rectifier.
The Product intended for use in: nephrostomy, cholecystectomy, drainage of abscesses and cysts.
Available with or without String Lock. The set includes a steel cannula and a polyethylene mandrel.
Distinctive features of the device:
SKATER™ All-Purpose, Nephrostomy, & Biliary Drainage Catheters
The SKATER™ catheters designed to promote maximum drainage flow. They formulated for patient comfort, kink resistance, easy insertion, and radiopacity. They used safely with ethyl alcohol and doxycycline.
Each Set Includes:
Key Product’s Attributes:
Key Product’s Attributes
SKATER ™ Centesis & Safety Centesis Catheters designed for use in percutaneous fluid outpatient clinics and low volume drainage procedures.
Key product’s attributes:
The vent plug allows; air out of the catheter during insertion and protects against fluid leakage.
SKATER Fix Catheter Fixation Device
The SKATER™ catheters provide suture-free security while offering patient comfort.
Key product’s advantages:
Epidermal part processed antiseptic provides reliable fixing without suturing the catheter to the skin
Installed for a period of 7 days or more
The presence of a transparent "window" at the exit site of the catheter
Attachable catheter size - 5 to 16Fr (1.7 to 5.3 mm)
Does not irritate the skin
Provides freedom of movement to the patient